Literature DB >> 6766509

Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats.

B R Goldin, S L Gorbach.   

Abstract

The epidemiologic patterns of large bowel cancer have implicated a diet high in beef as a risk factor. Another study has shown less colon cancer in Finns than in Danes. Among the possible explanations were the consumption of milk and fermented dairy products and the numbers of lactobacilli in the fecal flora, both of which were higher in the Finns. As a test of these hypotheses, 20 mg 1,2-dimethylhydrazine dihydrochloride/kg body weight was administered for 20 weeks to male inbred F344 rats. Rats consuming a beef diet simulating a "Western" diet had higher rates of colon cancer than did grain-fed rats (83% vs. 31%, respectively). Viable cultures of Lactobacillus acidophilus were fed to rats eating the meat diet; the rats were then challenged with 1,2-dimethylhydrazine dihydrochloride. The colon cancer incidence after a 20-week induction period was lower in the animals receiving the L. acidophilus (40% vs. 77% in controls), but no difference in incidence was discerned after a 36-week period. Thus dietary supplements of L. acidophilus seemed to increase the latency or induction time for experimental colon cancer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6766509     DOI: 10.1093/jnci/64.2.263

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  21 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities.

Authors:  Roberto Flores; Jianxin Shi; Mitchell H Gail; Jacques Ravel; James J Goedert
Journal:  Eur J Clin Invest       Date:  2012-03-13       Impact factor: 4.686

3.  Perspective: alpha-bugs, their microbial partners, and the link to colon cancer.

Authors:  Cynthia L Sears; Drew M Pardoll
Journal:  J Infect Dis       Date:  2010-12-08       Impact factor: 5.226

4.  Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.

Authors:  N P Hyland; A Houston; J M Keane; S A Joyce; C G M Gahan
Journal:  Results Probl Cell Differ       Date:  2020

5.  Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.

Authors:  B R Goldin; S L Gorbach; M Saxelin; S Barakat; L Gualtieri; S Salminen
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

6.  Effect of eriodictyol on preneoplastic lesions, oxidative stress and bacterial enzymes in 1,2-dimethyl hydrazine-induced colon carcinogenesis.

Authors:  P Mariyappan; T Kalaiyarasu; V Manju
Journal:  Toxicol Res (Camb)       Date:  2017-06-19       Impact factor: 3.524

Review 7.  The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

Authors:  M Andrea Azcárate-Peril; Michael Sikes; José M Bruno-Bárcena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

8.  Diet and colon cancer in Los Angeles County, California.

Authors:  R K Peters; M C Pike; D Garabrant; T M Mack
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

9.  Antimicrobial substance from a human Lactobacillus strain.

Authors:  M Silva; N V Jacobus; C Deneke; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

10.  Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content.

Authors:  Do Kyung Lee; Seok Jang; Eun Hye Baek; Mi Jin Kim; Kyung Soon Lee; Hea Soon Shin; Myung Jun Chung; Jin Eung Kim; Kang Oh Lee; Nam Joo Ha
Journal:  Lipids Health Dis       Date:  2009-06-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.